Table 5.
Type and Number of Dose Deviation at Weeks 3 and 6 in Bulky and Postoperative Groups.
| Type of Event | PO (n = 11) | B (n = 11) | B Versus PO P Valuea |
|---|---|---|---|
| n (%) | n (%) | ||
| Spinal cord maximum dose >45 Gy | 1 (9.1) | 2 (18.2) | 1.000 |
| Right parotid mean dose >26 Gy | -- | 3 (27.3) | .214 |
| Left parotid mean dose >26 Gy | -- | 5 (45.5) | .035 |
| CTV-HR coverage <95% | -- | 3 (27.3) | .214 |
| CTV-LR coverage <95% | 1 (9.1) | 5 (45.5) | .149 |
| CTV HR and/or LR coverage <95% | 1 (9.1) | 6 (54.1) | .063 |
| At least 1 event | 2 (18.2) | 8 (72.7) | .030 |
Abbreviations: B, bulky disease; CTV-HR, high-risk clinical target volumes; CTV-LR, low-risk clinical target volumes; PO, postoperative.
a P value from Fisher exact test.